Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Operating Expenses | 11,455 | 9,693 | 6,940 | 4,319 | 7,361 |
| Operating Income | -11,455 | -9,693 | -6,940 | -4,319 | -7,361 |
| Interest Expense | 4 | 3 | 4 | 3 | 5 |
| Other Income | 14 | 7 | 5 | 2 | 2,002 |
| Pre-tax Income | -11,445 | -9,689 | -6,939 | -4,320 | -5,364 |
| Net Income Continuous | -11,445 | -9,689 | -6,939 | -4,320 | -5,364 |
| Net Income | $-11,445 | $-9,689 | $-6,939 | $-4,320 | $-5,364 |
| EPS Basic Total Ops | -392.96 | -714.67 | -1,571.38 | -2,931.23 | -4,850.13 |
| EPS Basic Continuous Ops | -392.93 | -713.99 | -1,215.02 | -2,934.92 | -4,844.41 |
| EPS Diluted Total Ops | -392.96 | -714.67 | -1,571.38 | -2,931.23 | -4,850.13 |
| EPS Diluted Continuous Ops | -392.93 | -713.99 | -1,215.02 | -2,934.92 | -4,844.41 |
| EBITDA(a) | $-11,247 | $-9,614 | $-6,914 | $-4,276 | $-6,759 |